Want to see EVH full AI Analyst Report?
Evolent Health (EVH) Stock Statistics & Valuation Metrics
Total Valuation
Evolent Health has a market cap or net worth of $518.02M. The enterprise value is $1.21B.
- Market Cap
- $518.02M
- Enterprise Value
- $1.21B
Share Statistics
Evolent Health has 113,105,520 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 113,105,520
- Owned by Insiders
- 2.76%
- Owned by Institutions
- 29.21%
Financial Efficiency
Evolent Health’s return on equity (ROE) is -1.29 and return on invested capital (ROIC) is -0.29%.
- Return on Equity (ROE)
- -1.29
- Return on Assets (ROA)
- -0.28
- Return on Invested Capital (ROIC)
- -0.29%
- Return on Capital Employed (ROCE)
- -0.00
- Revenue Per Employee
- 446.72K
- Profits Per Employee
- -127.26K
- Employee Count
- 4,200
- Asset Turnover
- 0.99
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Evolent Health is -1.06. Evolent Health’s PEG ratio is 0.00.
- PE Ratio
- -1.06
- PS Ratio
- 0.23
- PB Ratio
- 1.43
- Price to FCF
- 14.45
- Price to Operating Cash Flow
- 8.21
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Evolent Health had revenue of 1.88B and earned -534.51M in profits. Earnings per share was -5.07.
- Revenue
- 1.88B
- Gross Profit
- 284.03M
- Operating Income
- -4.43M
- Pretax Income
- -534.64M
- Net Income
- -534.51M
- EBITDA
- -361.31M
- Earnings Per Share (EPS)
- -5.07
Cash Flow
In the last 12 months, operating cash flow was 64.88M and capital expenditures -28.23M, giving a free cash flow of 36.66M billion.
- Operating Cash Flow
- 64.88M
- Free Cash Flow
- 36.66M
- Free Cash Flow per Share
- 0.32
Dividends & Yields
Evolent Health pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 7.05%
- Earnings Yield
- -97.08%
Stock Price Statistics
- Beta
- 0.43
- 52-Week Price Change
- -23.67%
- 50-Day Moving Average
- 4.17
- 200-Day Moving Average
- 3.89
- Relative Strength Index (RSI)
- 54.39
- Average Volume (3m)
- 2.30M
Important Dates
Evolent Health upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Feb 24, 2027
- Ex-Dividend Date
- ―
Financial Position
Evolent Health as a current ratio of 1.31, with Debt / Equity ratio of 238.37%
- Current Ratio
- 1.31
- Quick Ratio
- 1.31
- Debt to Market Cap
- 2.12
- Net Debt to EBITDA
- -2.32
- Interest Coverage Ratio
- -0.08
Taxes
In the past 12 months, Evolent Health has paid -126.00K in taxes.
- Income Tax
- -126.00K
- Effective Tax Rate
- 0.00
Enterprise Valuation
Evolent Health EV to EBITDA ratio is -4.15, with an EV/FCF ratio of 36.69.
- EV to Sales
- 0.57
- EV to EBITDA
- -4.15
- EV to Free Cash Flow
- 36.69
- EV to Operating Cash Flow
- 20.73
Balance Sheet
Evolent Health has $148.25M in cash and marketable securities with $973.05M in debt, giving a net cash position of -$824.79M billion.
- Cash & Marketable Securities
- $148.25M
- Total Debt
- $973.05M
- Net Cash
- -$824.79M
- Net Cash Per Share
- -$7.29
- Tangible Book Value Per Share
- -$7.61
Margins
Gross margin is 12.10%, with operating margin of -0.99%, and net profit margin of -21.67%.
- Gross Margin
- 12.10%
- Operating Margin
- -0.99%
- Pretax Margin
- -21.54%
- Net Profit Margin
- -21.67%
- EBITDA Margin
- -13.84%
- EBIT Margin
- -18.56%
Analyst Forecast
The average price target for Evolent Health is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $6.00
- Price Target Upside
- 31.00% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 10
- Revenue Growth Forecast
- 14.06%
- EPS Growth Forecast
- -189.46%
Scores
- Smart Score
- 8
- AI Score
- 58
